16 July 2009 - Indena has been granted a Certificate of Sustainability of the European Pharmacopoeia (CEP) for Paclitaxel from semisynthesis, obtained through its own patented process.
The CEP was granted by the European Directorate for the Quality of Medicines.
The purpose of the CEP certification procedure is to provide proof that the quality of the substances used in human and veterinary medicines are suitably controlled by the relevant monographs of the European Pharmacopoeia.
